About 1 result found for searched term "796967-16-3" (0.144 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1640 | ABT-869 | VEGFR/PDGFR |
| Linifanib | ||
| ABT-869 (Linifanib) is an ATP-competitive, multi-targeted RTK inhibitor that is completely effective against all members of VEGFR and PDGFR. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
